0000886163-18-000120.txt : 20180817
0000886163-18-000120.hdr.sgml : 20180817
20180817193721
ACCESSION NUMBER: 0000886163-18-000120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180816
FILED AS OF DATE: 20180817
DATE AS OF CHANGE: 20180817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sunil
CENTRAL INDEX KEY: 0001503062
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 181026863
MAIL ADDRESS:
STREET 1: 11085 NORTH TORREY PINES RD., SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-08-16
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001503062
Patel Sunil
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2018-08-16
4
M
0
5000
9.6
A
44806
D
Common Stock
2018-08-16
4
M
0
7335
10.12
A
52141
D
Common Stock
2018-08-16
4
M
0
7335
12.53
A
59476
D
Common Stock
2018-08-16
4
M
0
7335
32.3
A
66811
D
Common Stock
2018-08-16
4
S
0
42287
240.0456
D
24524
D
Non-Qualified Stock Option (right to buy)
9.6
2018-08-16
2018-08-16
4
M
0
5000
0.0
D
2020-10-07
Common Stock
5000
0
D
Non-Qualified Stock Option (right to buy)
10.12
2018-08-16
2018-08-16
4
M
0
7335
0.0
D
2021-06-01
Common Stock
7335
0
D
Non-Qualified Stock Option (right to buy)
12.53
2018-08-16
2018-08-16
4
M
0
7335
0.0
D
2022-05-31
Common Stock
7335
0
D
Non-Qualified Stock Option (right to buy)
32.3
2018-08-16
2018-08-16
4
M
0
7335
0.0
D
2023-06-11
Common Stock
7335
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.31 to $242.68, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable in 36 successive monthly installments upon completion of each calendar month of service beginning on the grant date.
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date.
Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date.
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date.
By: Charles S. Berkman For: Sunil Patel
2018-08-17